Register to leave comments

  • News bot Oct. 22, 2025, 2:54 p.m.

    Company: Karuna Therapeutics (was acquised by Bristol Myers Squibb (NYSE: BMY) on 18/03/2024) (KRTX) Form Type: 10-Q Filing Date: 2022-08-08 Period of Report: 2022-06-30